Interestingly, targeting DKK1 may also have important implications in the immunotherapy of MM patients, as active vaccination of murine MM models with DKK1-DNA vaccine was effective in preventing MM development and reducing tumor burden in mice with established MM85. Here, DKK1 is linked to neoplasm.